Viatris Inc.
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.
Drug Manufacturers - Specialty & Generic
US, Canonsburg [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 0.17 | 1.57 | 1.57 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 5.86 | 15.68 | 14.81 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | -1.81 | 16.75 | 17.05 | |
| Cash | 2.90 | 0.93 | 0.90 | |
| Capex | 74.61 | -0.04 | -0.17 | |
| Free Cash Flow | 103.27 | 0.47 | 0.23 | |
| Revenue | -3.99 | 3.06 | 3.19 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -1.28 | 0.42 | 0.42 | |
| Operating Margin | -19.77 | 0.11 | 0.14 | |
| ROA | -85.02 | < 0.005 | -0.02 | |
| ROE | -84.79 | < 0.005 | -0.04 | |
| ROIC | -51.55 | < 0.005 | 0.01 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of VTRS is permitted for members.
5
Growth
The "Growth Entry" for the Focus of VTRS is permitted for members.
6
Leverage & Liquidity